Why did 4596.T stock spike on 27 Feb 2026?

4596.T stock spiked on heavy volume after renewed investor interest in its ophthalmology pipeline and device projects; the increased trading suggests event-driven buying rather than routine rebalancing.

What are the key valuation metrics for 4596.T stock?

Key metrics: **EPS -19.46**, **PE -12.33**, **bookValuePerShare JPY 26.41**, **cashPerShare JPY 27.93**, and **priceToSales 718.56**, showing early-stage biotech valuation dynamics.

What is Meyka AI’s short-term forecast for 4596.T stock?

Meyka AI's forecast model projects a monthly target of **JPY 246.86**, implying **+2.86%** upside from **JPY 240.00**; forecasts are model-based and not guarantees.

How should traders manage risk on 4596.T stock after the surge?

Given high ATR **37.60** and volume-driven volatility, use reduced position sizes, define stop losses, and monitor trial or earnings updates to limit downside from possible catalyst reversals.

JP Stocks

4596.T Kubota Pharmaceutical (JPX) +22.45% to JPY240.00 27 Feb 2026: volume spike

ByDanny Kontos February 27, 2026February 27, 2026

Kubota Pharmaceutical Holdings (4596.T) led high-volume movers as the stock climbed 22.45% to JPY 240.00 on 27 Feb 2026 at market close on the JPX in Japan. The move came with an outsized volume of 26,098,400.00 shares versus an average of 7,404,937.00, marking a relative volume of 3.52. Traders flagged clinical and pipeline news as a catalyst, pushing volatility well above the Healthcare sector’s daily move of +0.41%. This report focuses on the intraday drivers, valuation metrics, Meyka AI grading, and short-term 4596.T stock outlook for active traders and investors.